Navigation Links
GenVault's GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots
Date:8/5/2009

p>

"GenSolve(TM) serves to enable highly efficient recovery of DNA from very precious neonatal blood samples that are available in limited supply and archived for long periods in a dry state. Of major significance is the fact that DNA recovered by GenSolve(TM) is suitable for downstream analysis on state-of-the-art technology, allowing us to capitalize on the resources we have to facilitate population scale studies", said Professor Gary Shaw of the Department of Pediatrics at Stanford University Medical School.

GenSolve(TM) recovers DNA from blood samples, collected and stored dry on a range of paper matrices (Guthrie cards, FTA paper and GenPlates(TM)), in a double stranded and non-denatured form which exhibits no fragmentation up to 40kb.

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

    EDITORIAL CONTACTS:
    Bret Dash, Director of Marketing
    (760) 717 3774
    bdash@genvault.com

Available Topic Expert(s): For in
'/>"/>

SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
2. Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting
3. ABR-Affinity BioReagents Inks New Distribution Agreements in Switzerland and Hungary
4. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
5. ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas
6. ABR-Affinity BioReagents Announces Its Continued Support for the Society for Neuroscience Annual Meeting in San Diego, November 3 - 7, 2007
7. ABR -- Affinity BioReagents Announces Launch of New Website
8. ABR-Affinity BioReagents Expands 100% Quality Guarantee
9. Greenway Medical Technologies EHR Solution, PrimeSuite, Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Sciences, a 2009 CMS Qualified PQRI Registry
10. New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care
11. CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... say that phthalates actually cause the condition, ... -- Common chemicals found in plastic toys and ... breasts in boys, preliminary research suggests. , ... for pediatricians, adds fuel to the debate over ... questioned by some scientists. The chemical industry claims ...
(Date:12/15/2009)... benefits of imaging outweigh the risks , , TUESDAY, Dec. ... serious risk to people with heart pacemakers, researchers warn. ... to a simulated MRI magnetic field and then measured ... pacemaker lead, where it would touch the interior of ... pulses caused certain pacemakers to deliver a drastically altered ...
(Date:12/15/2009)... -- Accelify is proud to announce the addition of ... will serve as Director of Development in the State ... of Advisors. ,, David Tokofsky was elected ... Education in June 1995. As the Board Member for ... stretching from Northeast Los Angeles through East Los Angeles ...
(Date:12/15/2009)... SMITHFIELD, R.I., Dec. 15 Mergers and ... to expand their reach globally or complete a ... including the integration of safety programs. ,, A ... " Best Practices in a Hearing Conservation Program: ... US Airways and America West led the newly ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Autoimmune Diseases Therapeutics - Market Forecasts ... and Deals Analysis ,, ... ,, The author has released ...
Breaking Medicine News(10 mins):Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 23
... of HDL level, study found , MONDAY, Aug. 27 (HealthDay ... do not protect against increased blood pressure in ... The study of more than 21,000 men, ages 20-29 and ... the younger men to blood pressure increases associated with heavy ...
... Using magnetic resonance (MR) images of the brain, researchers ... and disability in patients with multiple sclerosis (MS), according ... Radiology. , Based on these findings, physicians may ... identify patients at risk for developing progressive disease, said ...
... scientists have found the first evidence that a specific form ... increase the risk for estrogen-induced cancers of the breast and ... the animal equivalent of multiple sclerosis. , IMPACT: ... for anti-inflammatory drugs to help prevent flare-ups of their physical ...
... should be available an open question, researcher says , , ... from cardiac arrest while on school grounds, it makes the ... school property is rare, and most of the victims are ... medical service calls in the Seattle area, researchers found that ...
... reduce incidence, experts say, , , MONDAY, Aug. 27 (HealthDay News) ... be responsible for most cervical cancers, may also be at ... new research suggests. , Although the rate of most head ... years because more people have stopped smoking, the rate of ...
... more dangerous for women than men, major study finds , ... are at significantly increased risk for head and neck cancers ... oral cavity, and throat, says a U.S. National Cancer Institute ... men and women between 1995 and 2000. , The analysis ...
Other Medicine News:Health News:New MRI finding sheds light on multiple sclerosis disease progressio 2Health News:Heart Attacks at School Involve More Adults Than Kids 2Health News:Heart Attacks at School Involve More Adults Than Kids 3Health News:Oral Sex Implicated in Some Throat and Neck Cancers 2Health News:Oral Sex Implicated in Some Throat and Neck Cancers 3
(Date:12/15/2009)... Medical, Inc. (Nasdaq: NXTM ), a leading ... a group of its home hemodialysis patients and ... conventional (non-dialysis) Caribbean cruise with their NxStage® System ... Freedom Cruise: We,re Taking Home Dialysis to Sea," ... and returns on January 10, 2010. The ...
(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: ... on significant strategic and financial initiatives at its ... Conference is hosted by Peter H. Soderberg, president ... on the following topics: ,, Status of ... development and financial updates Smart technologies that ...
(Date:12/15/2009)... Inc., a family-owned Texas company that produces the ... a patented medical device being utilized by U.S. ... to lessen the effects of fluid-induced hypothermia ... Tahoe as the first-ever recipient of their "Thermal Angel ... is a California-based nonprofit emergency helicopter service headquartered in ...
Breaking Medicine Technology:Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 1Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 3Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 1Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 2Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 3Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 4Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 1Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 2Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 3Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 4Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 5Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 6Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 7Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 8Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 9Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 10Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 11Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 12Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 13Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 14Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 15Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 16Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 17Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 18Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 19Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 20Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 21Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 22Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 23Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 24Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 25Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 26Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 27Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 28Medco Delivers Record Third Quarter 2009 GAAP Diluted EPS of 240 69 3B Diluted EPS Excluding Amortization of Intangible Assets of 240 75 5944 29
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
... been developing diverse medical products ... Our medical-surgical products have earned ... quality and customer satisfaction. Graham-Fields ... Labtron® line of diagnostic instruments, ...
... Nebulizers deliver particulate humidity in the 3 ... secretion patients. For your convenience, Thera-Mist® nebulizers ... of sterile water., ,The P30000N, for ... 20-50% with a total flow range of ...
... Our Hand Held Nebulizer can be held ... It has a built in spill column, ... legs for medication setups and 7 feet of ... baffle plate maintain small particle size and sustain ...
Medicine Products: